CN102085333A - Medicament for treating leucoderma - Google Patents
Medicament for treating leucoderma Download PDFInfo
- Publication number
- CN102085333A CN102085333A CN 201110009937 CN201110009937A CN102085333A CN 102085333 A CN102085333 A CN 102085333A CN 201110009937 CN201110009937 CN 201110009937 CN 201110009937 A CN201110009937 A CN 201110009937A CN 102085333 A CN102085333 A CN 102085333A
- Authority
- CN
- China
- Prior art keywords
- parts
- treatment
- leukodermic medicine
- radix
- leukodermic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicament for treating leucoderma, which is prepared from 10 parts of angelica, 10 parts of radix paeoniae alba, 15 parts of motherwort, 10 parts of radix curcumae, 15 parts of wild rue, 15 parts of cocklebur fruit, 15 parts of tuckahoe and 15 parts of pyrite. The clinical treatment on thousands of patients indicates that the effective rate of leucoderma is 95%, and the cure rate is higher than 80%.
Description
Technical field
The present invention relates to the leukodermic medicine of a kind of treatment.
Background technology
Vitiligo is to take off to lose with skin pigment to present leukasmus or milky white mottle and gain the name.Skin pigment is a dermal melanin, and dermal melanin is present in skin and the intrafollicular melanocyte, and the melanin that melanocyte produces is converted into DOPA by tryrosinase under the tryrosinase effect, forms through a series of biochemical processes again.When this process generation obstacle, just cause that depigmentation is sample day shift.
Traditional medicine thinks that though vitiligo is long in appearance, root is at internal organs.System is because of easypro in feelings will, disharmony between QI and blood, and blockage of the vessel is obstructed, and chosure of pores is due to the failure of skin and muscle to be nourished.Also skin is the mirror of internal organs just, and the disease of the vital organs of the human body all shows on the skin.
Vitiligo is diagnosed well, and refractory is healed, and leukodermic morbidity is on the rise.
Summary of the invention
Technical problem to be solved by this invention provides the leukodermic medicine of a kind of treatment.
The present invention adopts following technical scheme:
The leukodermic medicine of a kind of treatment adopts following component to make: 10 parts of Radix Angelicae Sinensis, 10 parts of the Radix Paeoniae Albas, 15 parts of Herba Leonuris, 10 parts of Radix Curcumaes, 15 parts of Fructus Tribulis, 15 parts of Fructus Xanthii, 15 parts in Poria, 15 parts of Pyritums.
Treating leukodermic medicine can be made into: oral liquid, decoct, pill, granule can also be made outer liniment<tincture 〉: adding 65% jowar wine with the top, to soak after ten days bottling standby, wipes the affected part every day three times.
The prescription effect:
Enrich blood, blood circulation promoting and blood stasis dispelling, speckle dispelling, the supplementation with copper ion, nourishing melanin generates.
Pharmaceutical analysis:
Radix Angelicae Sinensis: enrich blood, invigorate blood circulation, pain relieving, intestine moistening.
The Radix Paeoniae Alba: the yin fluid astringing that nourishes blood, easing the affected liver to relieve pain, suppressing liver-YANG
Herba Leonuri: blood circulation promoting and blood stasis dispelling, inducing diuresis to remove edema.
Radix Curcumae: promoting blood circulation and stopping pain, promoting QI circulation for relieving depression, removing heat from blood clears away heart-fire, promoting the function of the gallbladder to alleviate jaundice.
Fructus Tribuli: the kidney invigorating, controlling nocturnal emission with astringent drugs, nourishing the liver to improve visual acuity.
Fructus Xanthii: clearing the nasal passage, wind-damp dispelling, pain relieving.
Poria: promoting diuresis to eliminate damp pathogen, spleen invigorating is calmed the nerves.
Pyritum: eliminating stasis to stop pain, whereabouts are for stagnating.
Clinical efficacy is to over thousands of routine therapy of vitiligo effective percentage 95% cure rate more than 80%.
The specific embodiment
Below in conjunction with specific embodiment, the present invention is described in detail.
Treat leukodermic medicine prescription: Radix Angelicae Sinensis 10 grams, the Radix Paeoniae Alba 10 grams, Herba Leonuri 15 grams, Radix Curcumae 10 grams, Fructus Tribuli 15 grams, Fructus Xanthii 15 grams, Poria 15 grams, Pyritum 15 grams.Can be made into: oral liquid, decoct, pill, granule can also be made outer liniment<tincture 〉: adding 65% jowar wine with the top, to soak after ten days bottling standby, wipes the affected part every day three times.
Clinical efficacy is to over thousands of routine therapy of vitiligo effective percentage 95% cure rate more than 80%.
Du Jia village, Jia Qu township, case 1. Pucheng County, written elegant woman 34 years old suffers from vitiligo for many years, treats leukodermic medicine treatment two courses of treatment (30 days course of treatment) recovery from illness with the present invention.
Daylight village, macropore township, case 2. Pucheng County, gorgeous women 23 years old of Jiang Yan suffers from vitiligo.Treat two recoveries from illness course of treatment of leukodermic medicine treatment with the present invention.
Eternally happy village, town, the stingy shop of case 3. Weinan Cities, cloudy roc man suffered from vitiligo in 21 years old, treated three recoveries from illness course of treatment of leukodermic medicine treatment with the present invention.
Dang Ding village, Su Fang town, case 4. Pucheng County, the Jing Chao man suffered from vitiligo in 21 years old, treated five recoveries from illness course of treatment of leukodermic medicine treatment with the present invention.
Auspicious plateau village, case Dong Yang township, 5. Pucheng County, bavin ice man suffered from vitiligo in 16 years old, treated two recoveries from illness course of treatment of leukodermic medicine treatment with the present invention.
Chao Yi town, case 6. Dali County, Lu change gorgeous women 36 years old suffers from vitiligo, treats five recoveries from illness course of treatment of leukodermic medicine treatment with the present invention.
Should be understood that, for those of ordinary skills, can be improved according to the above description or conversion, and all these improvement and conversion all should belong to the protection domain of claims of the present invention.
Claims (3)
1. the leukodermic medicine of treatment is characterized in that, adopts following component to make: 10 parts of Radix Angelicae Sinensis, 10 parts of the Radix Paeoniae Albas, 15 parts of Herba Leonuris, 10 parts of Radix Curcumaes, 15 parts of Fructus Tribulis, 15 parts of Fructus Xanthii, 15 parts in Poria, 15 parts of Pyritums.
2. the leukodermic medicine of treatment according to claim 1 is characterized in that the leukodermic medicine of described treatment adopts one of following dosage form: oral liquid, decoct, pill, granule, tincture.
3. the leukodermic medicine of treatment according to claim 2 is characterized in that, described tincture preparation method is: described component is added the immersion of 65% jowar wine bottle standby after ten days.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011100099371A CN102085333B (en) | 2011-01-18 | 2011-01-18 | Medicament for treating leucoderma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011100099371A CN102085333B (en) | 2011-01-18 | 2011-01-18 | Medicament for treating leucoderma |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102085333A true CN102085333A (en) | 2011-06-08 |
CN102085333B CN102085333B (en) | 2012-07-04 |
Family
ID=44097494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011100099371A Expired - Fee Related CN102085333B (en) | 2011-01-18 | 2011-01-18 | Medicament for treating leucoderma |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102085333B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1099982A (en) * | 1993-09-09 | 1995-03-15 | 郭长香 | Medicine for treatment of leukoderma and its preparing method |
CN1335164A (en) * | 2001-07-26 | 2002-02-13 | 刘双义 | Leukoderma treating medicine and its prepn |
CN1824247A (en) * | 2005-12-22 | 2006-08-30 | 夏金陵 | Composition formula for treating leucoderma and its preparation method |
CN1840117A (en) * | 2006-01-26 | 2006-10-04 | 葛强 | Dermatosis-treating medicine |
-
2011
- 2011-01-18 CN CN2011100099371A patent/CN102085333B/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1099982A (en) * | 1993-09-09 | 1995-03-15 | 郭长香 | Medicine for treatment of leukoderma and its preparing method |
CN1335164A (en) * | 2001-07-26 | 2002-02-13 | 刘双义 | Leukoderma treating medicine and its prepn |
CN1824247A (en) * | 2005-12-22 | 2006-08-30 | 夏金陵 | Composition formula for treating leucoderma and its preparation method |
CN1840117A (en) * | 2006-01-26 | 2006-10-04 | 葛强 | Dermatosis-treating medicine |
Also Published As
Publication number | Publication date |
---|---|
CN102085333B (en) | 2012-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102327380B (en) | Chinese medicinal composition for treating knee osteoarthritis | |
CN100336527C (en) | Medicine for treating celevical vertebra disease | |
CN103446264A (en) | Physical therapy liquid for treating neck-shoulder and lumbocrural pains and preparation method thereof | |
CN102872301B (en) | Anti-rheumatism medicinal liquor and using method thereof | |
CN102335265A (en) | Chinese medicament for treating psoriasis | |
CN101983717A (en) | Traditional Chinese medicine for treating migraine | |
CN103656042A (en) | Medicine for treating herpes zoster | |
CN103006997B (en) | Medicine for treating post-craniotomy headache | |
CN102406796A (en) | Medicament for treating obesity of elderly people | |
CN101601767A (en) | A kind of Chinese medicine lotion for the treatment of calcaneodynia | |
CN102085333B (en) | Medicament for treating leucoderma | |
CN101181427B (en) | Externally used medicament for curing scaly tetter | |
CN102078432A (en) | Medicament for treating skin itch | |
CN1283284C (en) | Medicinal spirit for rheumatism | |
CN102000166B (en) | Medicinal liquor for treating rheumatic arthritis and chronic infectious arthritis | |
CN102327438A (en) | Liquid for strengthening bone and alleviating pain | |
CN1236806C (en) | Liver-tonifying stone-removing Chinese medicine | |
CN101856467A (en) | Chinese medicament for treating bone fractures | |
CN101940725A (en) | Chinese medicinal preparation for treating muscular dystrophy | |
CN105381098A (en) | Traditional Chinese medicine fumigating and washing agent for treating knee osteoarthritis and nursing method | |
CN101244200A (en) | Chinese medicine for treating mazopathy | |
CN103285289A (en) | Traditional Chinese medicine for treating arthralgia | |
CN107865959A (en) | Treat the Chinese medicine of type of depression of QI biliary system infection | |
CN105709009A (en) | Externally-used traditional Chinese medicine pain-relieving liquid used for treating cervical spondylosis | |
CN1583123A (en) | Medicinal spirit for rheumatism |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120704 Termination date: 20130118 |
|
CF01 | Termination of patent right due to non-payment of annual fee |